|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.28 SEK | -0.78% |
|
+1.99% | -51.33% |
NextCell Pharma AB reported earnings results for the full year ended August 31, 2022. For the full year, the company reported sales was SEK 5.59 million compared to SEK 3.91 million a year ago. Revenue was SEK 6.23 million compared to SEK 4.45 million a year ago.
Net loss was SEK 34.55 million compared to SEK 24.56 million a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -51.33% | 4.14M | |
| +33.63% | 50.85B | |
| -0.09% | 42.82B | |
| +49.62% | 42.03B | |
| -4.96% | 29.55B | |
| +11.18% | 26.11B | |
| -21.95% | 19.13B | |
| +8.61% | 13.05B | |
| +28.31% | 12.16B | |
| +24.73% | 12.08B |
NEXTCELL PHARMA AB 